文献速递免疫规划妇幼与学校卫生传染病防控与疫情报告

乌干达坎帕拉孕产妇埃博拉疫苗接种意愿:疫情后横断面研究

Willingness to receive Ebola vaccines among pregnant and lactating women in Kampala, Uganda: insights from a post-outbreak cross-sectional study.
PubMed 文献 · Vaccine · 2026-05-22

2023年在乌干达坎帕拉Kawempe国家转诊医院对424名孕产妇开展横断面调查,59.4%表示愿意接种埃博拉疫苗。既往新冠疫苗接种(aPR=1.32)和仅偏好注射型疫苗(aPR=1.54)与接种意愿正相关,担心副作用和缺乏认知是犹豫主因。

要点

  • 孕产妇埃博拉疫苗接种意愿为59.4%,安全担忧与认知不足是主要障碍。
  • 既往新冠疫苗接种者接种意愿更高(aPR=1.32,95%CI:1.02-1.70)。
  • 仅偏好注射型疫苗者意愿更高(aPR=1.54,95%CI:1.18-2.00)。

核心结论

  • 略超半数孕产妇愿意接种埃博拉疫苗,安全担忧和认知有限仍是重要障碍。
  • 既往新冠疫苗接种和偏好注射型疫苗与接种意愿正相关,提示信任和熟悉度影响接受度。

研究设计与样本

  • 2023年在乌干达坎帕拉Kawempe国家转诊医院对产前/产后服务的孕产妇开展横断面调查。
  • 共纳入424名参与者(212名孕妇、212名哺乳期妇女),使用结构化问卷收集数据。
  • 采用改良泊松回归分析,P值<0.05视为有统计学意义。

主要发现

  • 424名参与者中252人(59.4%)表示愿意接种埃博拉疫苗。
  • 既往新冠疫苗接种与意愿正相关(aPR=1.32;95%CI:1.02-1.70)。
  • 仅偏好注射型疫苗者相比接受口服或注射方式者意愿更高(aPR=1.54;95%CI:1.18-2.00)。
  • 不愿或不确定者(n=172)中,最常提及的犹豫原因是对副作用的恐惧(22.1%)和缺乏埃博拉疫苗认知(20.3%)。

临床怎么用

  • 针对孕产妇开展定制化风险沟通和社区参与,以提升埃博拉疫苗接受度。
  • 将孕产妇纳入疫苗规划,确保埃博拉病毒病疫情期间的公平保护。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Pregnant and lactating women face heightened risk of mortality due to Ebola disease during outbreaks, yet have historically been excluded from vaccine trials and emergency vaccination campaigns. This study assessed willingness to receive an Ebola vaccine and identified associated factors among pregnant and lactating women in Kampala-Uganda, in the aftermath of the 2022 Sudan ebolavirus outbreak and amid the COVID-19 pandemic. METHODS: A cross-sectional survey was conducted in 2023 among pregnant/lactating women receiving antenatal/postnatal services at Kawempe National Referral Hospital. Data were collected using a structured questionnaire adapted from the WHO SAGE Working Group on Vaccine Hesitancy and included additional items on Ebola vaccine attitudes, socio-demographics, prior vaccination experiences, vaccine preferences (oral vs injectable) and health status, including chronic illness. The primary outcome was willingness to receive an Ebola vaccine. Modified Poisson regression was done using STATA version 15 and a p-value <0.05 was considered statistically significant. RESULTS: Among 424 participants (212 pregnant, 212 lactating), 252(59.4%) expressed willingness to receive an Ebola vaccine. In multivariable analysis, willingness was significantly associated with previous COVID-19 vaccination (adjusted Prevalence Ratio [aPR] = 1.32; 95%CI:1.02-1.70) and a preference for injectable vaccines only, compared to those open to oral or injectable modes (aPR = 1.54; 95%CI:1.18-2.00). Among those who were unwilling or unsure (n = 172), the most cited reasons for hesitancy were fear of side effects (22.1%) and lack of awareness about Ebola vaccines (20.3%). CONCLUSION: While just over half of the pregnant and lactating women in this study were willing to receive an Ebola vaccine, concerns about safety and limited awareness remain important barriers. Prior COVID-19 vaccination and preference for injectable vaccines were positively associated with willingness, suggesting that trust and familiarity with vaccination influence acceptance. Tailored risk communication and community engagement, and inclusion in vaccine planning are essential to ensuring equitable protection during EVD outbreaks.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Katana EB, Kiiza D, Odongpiny EAL, et al. Willingness to receive Ebola vaccines among pregnant and lactating women in Kampala, Uganda: insights from a post-outbreak cross-sectional study. Vaccine. 2026. PMID: 42172692. doi:10.1016/j.vaccine.2026.128737

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。